Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis - BioSpace

Retrieved on: 2024-09-26 12:36:35

Tags for this article:

Click the tags to see associated articles and topics

Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis - BioSpace. View article details on hiswai:

Excerpt

New research has found that MS patients treated with anti-CD20 antibodies, such as Roche's Ocrevus, do not experience significantly slower ...

Article found on: www.biospace.com